Common Contracts
2 similar Exclusive License Agreement contracts by Sanguine Corp
NOTICE OF TERMINATION WHEREAS, on April 1, 2002, Sanguine Corporation (the "Company" and the "Licensor") entered into an Exclusive License Agreement with Ascendiant-South America, LLC, a Nevada limited liability corporation (the "Licensee"), pursuant...Exclusive License Agreement • October 7th, 2004 • Sanguine Corp • In vitro & in vivo diagnostic substances
WHEREAS, on April 1, 2002, Sanguine Corporation (the "Company" and the "Licensor") entered into an Exclusive License Agreement with Ascendiant-South America, LLC, a Nevada limited liability corporation (the "Licensee"), pursuant to which the Licensee agreed to certain minimum levels of annual production of the Licensed Products (the "Minimum Production"); and in the event the Licensee failed to achieve the Minimum Production, to pay a royalty to the Licensor; and
NOTICE OF TERMINATION WHEREAS, on February 15, 2002, Sanguine Corporation (the "Company" and the "Licensor") entered into an Exclusive License Agreement with Ascendiant-Asia, LLC, a Nevada limited liability corporation (the "Licensee"), pursuant to...Exclusive License Agreement • October 7th, 2004 • Sanguine Corp • In vitro & in vivo diagnostic substances
WHEREAS, on February 15, 2002, Sanguine Corporation (the "Company" and the "Licensor") entered into an Exclusive License Agreement with Ascendiant-Asia, LLC, a Nevada limited liability corporation (the "Licensee"), pursuant to which the Licensee agreed to certain minimum levels of annual production of the Licensed Products (the "Minimum Production"); and in the event the Licensee failed to achieve the Minimum Production, to pay a royalty to the Licensor; and
